alpha-MSH is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-12-29. Numbers and descriptions here follow the published literature rather than marketing material.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
Lyophilised peptide powder is comparatively stable when kept dry, cold and protected from light. Once dissolved, the molecule is exposed to hydrolysis, oxidation and microbial growth, and degradation accelerates at higher temperatures and in alkaline solution. Repeated freeze-thaw cycles concentrate solutes and promote aggregation. Handling guidance for research peptides commonly clusters around freezer temperatures for powder and short refrigerated use for reconstituted solutions, with pH control and sterile technique applied throughout.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Belongs to the melanocortin agonist family |
| Key substitutions | Nle4 and D-Phe7 | Improve resistance to enzymatic degradation |
| Molecular formula | C50H69N15O9 | Approximately 1024 g/mol |
| Regulatory status | Not approved as a medicine | Distributed as a research chemical |
| Common synonyms | Melanotan II, MT-II, MT-2 | Spelling varies across sources |
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Lyophilised melanotan-2 is comparatively robust when kept dry, cold and dark, and a desiccated powder stored at minus twenty degrees Celsius or below is generally expected to retain its chemical integrity for extended periods. In solution the peptide is far less stable, with degradation proceeding through oxidation of tryptophan and histidine residues, hydrolysis adjacent to the lactam bridge, and aggregation at higher concentrations. Repeated freeze-thaw cycling accelerates loss of the parent peak. Working aliquots are therefore prepared once, held cold, and used without letting the stock return to ambient temperature.
Quality assessment of research-grade peptide rests mainly on reversed-phase high-performance liquid chromatography for purity and on mass spectrometry for identity confirmation. A single main peak above a stated threshold, commonly ninety-eight percent by peak area, is the usual release criterion applied by suppliers. Independent analyses commissioned by laboratories and consumer organisations have repeatedly reported discrepancies between label claims and measured content, including truncated sequences, residual trifluoroacetate, and lower-than-declared peptide mass. Those findings do not establish that every supplier is unreliable, but they indicate that purity figures printed on a vial are claims requiring verification rather than settled facts.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
== Outlook == Individuals with coeliac disease have a higher risk of developing cancer in certain parts of the gastrointestinal tract (oropharynx, oesophagus, and small intestine) compared to those without the disease. Small intestinal lymphoma is the most common cancer caused by complications of coeliac disease; however, it is still considered a rare complication. The prognosis for enteropathy‐associated T‐cell lymphoma (EATL) is poor with low survival rates. Risk factors for developing cancer among those with coeliac disease include older age and refractory coeliac disease. Coeliac disease also increases mortality risk; however, the extent of the increase is inconsistent across research.
== Research == Myopathies have been modeled with cell culture systems of muscle from healthy or diseased tissue biopsies. Another source of skeletal muscle and progenitors is provided by the directed differentiation of pluripotent stem cells. Research on skeletal muscle properties uses many techniques. Electrical muscle stimulation is used to determine force and contraction speed at different frequencies related to fiber-type composition and mix within an individual muscle group. In vitro muscle testing is used for more complete characterization of muscle properties. The electrical activity associated with muscle contraction is measured via electromyography (EMG). Skeletal muscle has two physiological responses: relaxation and contraction. The mechanisms for which these responses occur generate electrical activity measured by EMG. Specifically, EMG can measure the action potential of a skeletal muscle, which occurs from the hyperpolarization of the motor axons from nerve impulses sent to the muscle. EMG is used in research for determining if the skeletal muscle of interest is being activated, the amount of force generated, and an indicator of muscle fatigue. The two types of EMG are intra-muscular EMG and the most common, surface EMG. The EMG signals are much greater when a skeletal muscle is contracting versus relaxing. However, for smaller and deeper skeletal muscles the EMG signals are reduced and therefore are viewed as a less valued technique for measuring the activation.
On February 26, the FDA warned a California manufacturer of a kratom product called "Mitrasafe" that the supplement was not confirmed as safe, was not approved as a dietary supplement or drug, and was illegal for interstate commerce. Although it was a federally legal dietary supplement, kratom was not approved as a therapeutic agent in the United States due to the poor quality of the research. In November 2017, the FDA cited serious concerns over the marketing and effects (including death) associated with the use of kratom in the United States, stating that "There is no reliable evidence to support the use of kratom as a treatment for opioid use disorder; there are currently no FDA-approved therapeutic uses of kratom... and the FDA has evidence to show that there are significant safety issues associated with its use."
Sources: en.wikipedia.org
), i.e. a nonlinear set of differential equations with periodically varying parameters. It is well known that this class of dynamical systems may undergo very interesting and complex phenomena of nonlinear parametric resonance. It is easy to see that if:
=== August === 1 August: The second Donald Trump administration raises tariffs on New Zealand exports to the United States to 15 percent. Visual effects company Wētā FX proposes laying off 100 jobs in its support departments based in Wellington. 4 August: The New Zealand Government announces plans to scrap the National Certificate of Educational Achievement (NCEA) secondary school qualification. A name suppression order lapses for former Deputy Commissioner of Police Jevon McSkimming, who was charged in June 2025 with eight counts of possessing objectionable material including child sexual exploitation and bestiality over a four-year period. 5–6 August — An RNZAF C-130J Hercules evacuated three personnel of the United States National Science Foundation from McMurdo Station. 6 August: The Christchurch-based wool factory Wild Earth Yarns acquires the woollen dye house and spinning mill of the liquidated Napier-based company Design Spun. Hato Hone St John proposes scrapping various community voluntary programmes including hospital volunteers, community carers and pet therapy services as part of a review of its services; affecting about 1,100 people. 8 August – The Japanese Navy makes a stop-over in Wellington for the first time since 1936. 9–10 August – Prime Minister Luxon hosts Australian Prime Minister Anthony Albanese in Queenstown for annual bilateral head of government talks. 10 August — Gloriavale Christian Community's Overseeing Shepherd Howard Temple resigns after pleading guilty to 12 charges of sexual offending against women and girls last month.
Sensory gating A process by which the brain filters out redundant or unnecessary stimuli from all the sensory inputs, often studied in schizophrenia research. Sensory map An organized representation of sensory information in the brain. For example, the somatotopic map in the primary somatosensory cortex. Serotonin A neurotransmitter involved in mood, sleep, appetite, and cognition. Dysregulation of serotonin systems is linked to depression and anxiety disorders. Short-term memory The capacity to hold a small amount of information in an active, readily accessible state for a short period of time. Often contrasted with long-term memory. Sleep spindle A burst of oscillatory brain activity visible on an EEG during Stage 2 non-REM sleep. Thought to play a role in memory consolidation. Somatic nervous system A component of the peripheral nervous system responsible for voluntary control of body movements via skeletal muscles. Somatosensory system The part of the sensory system concerned with the conscious perception of touch, pressure, pain, temperature, position, movement, and vibration. Spasticity A condition of increased muscle tone (hypertonia) and exaggerated reflexes, often resulting from damage to upper motor neurons. Spatial memory The part of memory responsible for recording information about one’s environment and spatial orientation. Heavily dependent on the hippocampus. Spike-timing-dependent plasticity (STDP) A form of synaptic plasticity in which the timing of neuronal spikes determines whether synapses are strengthened or weakened.
Sources: en.wikipedia.org
Topilutamide, known more commonly as fluridil and sold under the brand name Eucapil, is an antiandrogen medication which is used in the treatment of pattern hair loss in men and women. It is used as a topical medication and is applied to the scalp. Topilutamide belongs to a class of molecules known as perfluoroacylamido-arylpropanamides. Topilutamide is a nonsteroidal antiandrogen (NSAA), or an antagonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). Topilutamide was introduced for medical use in 2003. It is marketed only in the Czech Republic and Slovakia. The patent for Topilutamide expired in 2020.
== Rainforest Alliance == The Rainforest Alliance is an international nonprofit organization that works to conserve biodiversity and promote the fair treatment of workers. Rainforest Alliance Certified coffee farms must meet standards that include the protection of farms, soils, waterways, and wildlife; the workers are in safe working conditions; and the workers enjoy suitable housing, medical care, and access to schools for their children. 80% of Second Cup coffees are Rainforest Alliance Certified. As of the end of 2011, Second Cup offered ten whole-leaf tea blends and herbal tisanes that were fair trade certified.
==== Polish ==== Alliance of Poles in America - Founded on September 22, 1895, in Ohio as Alliance of Poles. Added "of America" in 1914. Headquarters in Cleveland. Locals are called "Groups", regional groups "Circles", and the national structure is the "Central Body", which meets quadrennially. Membership is open to both sexes from the start. Now open to anyone 15–65, of good moral character, physically and mentally healthy, Polish or Lithuanian by birth or consanguinity. Has no ritual, but it does have an oath. Had 16,000 in the late 1960s, and 20,000 in 72 locals in 1979. Had 20,000 members in 1994. Federal Life Insurance of America - Founded in 1911 as a pressure group with the US Catholic church for Polish interests. Its original name was the Federation of Polish Catholic Laymen. The insurance aspect was added in 1913, and the name changed to the Federation of Poles in America. Became Federal Life Insurance of America in 1924. Local groups are called "Lodges"; in 1979 there were 28 lodges in 7 states. The national convention meets quadrennially. Poles or people of Polish descent are eligible. A women's division was added in 1940. There were 5,000 members in 1960, and 5,543 in 1979. There were 4,476 in 1994. Sent food and clothing to Poland and Polish refugees during World War II; aided the Ochronka Orphanage in Poland since the war; also supports International Folk Fair in Milwaukee. Polish Beneficial Association - Founded in 1899 in Philadelphia and headquartered there. Locals are called "groups". National convention meets quadrennially.
Sources: en.wikipedia.org
It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.
No regulatory agency has approved it for any indication. It is encountered as a research chemical sold outside pharmaceutical supply chains. Products marketed this way are not subject to the manufacturing and labeling requirements that apply to approved drugs.
Reports describe increased skin pigmentation as well as side effects such as nausea, flushing, and changes to existing moles. Much of the evidence comes from small studies and case reports rather than large trials. The long-term safety profile is therefore uncertain.
Mass spectrometry combined with liquid chromatography provides both molecular weight confirmation and a measure of related impurities. Tandem mass spectrometry adds sequence information. A purity percentage reported without a mass measurement does not confirm what the material is.